BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 17825016)

  • 1. Sequential monitoring of randomization tests: stratified randomization.
    Zhang Y; Rosenberger WF; Smythe RT
    Biometrics; 2007 Sep; 63(3):865-72. PubMed ID: 17825016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptive randomization for multiarm comparative clinical trials based on joint efficacy/toxicity outcomes.
    Ji Y; Bekele BN
    Biometrics; 2009 Sep; 65(3):876-84. PubMed ID: 19173694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A note on P-values under group sequential testing and nonproportional hazards.
    Gillen DL; Emerson SS
    Biometrics; 2005 Jun; 61(2):546-51. PubMed ID: 16011703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing homogeneity of two zero-inflated Poisson populations.
    Tse SK; Chow SC; Lu Q; Cosmatos D
    Biom J; 2009 Feb; 51(1):159-70. PubMed ID: 19219907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient estimation for patient-specific rates of disease progression using nonnormal linear mixed models.
    Zhang P; Song PX; Qu A; Greene T
    Biometrics; 2008 Mar; 64(1):29-38. PubMed ID: 17501938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adaptive biased urn randomization in small strata when blinding is impossible.
    Schouten HJ
    Biometrics; 1995 Dec; 51(4):1529-35. PubMed ID: 8589238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of randomization techniques for clinical trials with data from the HOMERUS-trial.
    Verberk WJ; Kroon AA; Kessels AG; Nelemans PJ; Van Ree JW; Lenders JW; Thien T; Bakx JC; Van Montfrans GA; Smit AJ; Beltman FW; De Leeuw PW
    Blood Press; 2005; 14(5):306-14. PubMed ID: 16257877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Judgement post-stratification for designed experiments.
    Du J; MacEachern SN
    Biometrics; 2008 Jun; 64(2):345-54. PubMed ID: 17888038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blinded assessment of treatment effects utilizing information about the randomization block length.
    Miller F; Friede T; Kieser M
    Stat Med; 2009 May; 28(12):1690-706. PubMed ID: 19340815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptive design and estimation in randomized clinical trials with correlated observations.
    Yin G; Shen Y
    Biometrics; 2005 Jun; 61(2):362-9. PubMed ID: 16011682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chop-lump tests for vaccine trials.
    Follmann D; Fay MP; Proschan M
    Biometrics; 2009 Sep; 65(3):885-93. PubMed ID: 19210727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exact permutational tests for group sequential clinical trials.
    Mehta CR; Patel N; Senchaudhuri P; Tsiatis A
    Biometrics; 1994 Dec; 50(4):1042-53. PubMed ID: 7786986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discussions.
    Have TT
    Biometrics; 2007 Sep; 63(3):654-5. PubMed ID: 17824997
    [No Abstract]   [Full Text] [Related]  

  • 14. A modified pseudolikelihood approach for analysis of longitudinal data.
    Wang YG; Zhao Y
    Biometrics; 2007 Sep; 63(3):681-9. PubMed ID: 17825002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Principal stratification designs to estimate input data missing due to death.
    Frangakis CE; Rubin DB; An MW; MacKenzie E
    Biometrics; 2007 Sep; 63(3):641-9; discussion 650-62. PubMed ID: 17824995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic comparison of Kaplan-Meier proportions: monitoring a randomized clinical trial with a long-term binary endpoint.
    Brittain E; Follmann D; Yang S
    Biometrics; 2008 Mar; 64(1):189-97. PubMed ID: 17680830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring and reporting of the Women's Health Initiative randomized hormone therapy trials.
    Anderson GL; Kooperberg C; Geller N; Rossouw JE; Pettinger M; Prentice RL
    Clin Trials; 2007; 4(3):207-17. PubMed ID: 17715246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marginal analysis of correlated failure time data with informative cluster sizes.
    Cong XJ; Yin G; Shen Y
    Biometrics; 2007 Sep; 63(3):663-72. PubMed ID: 17825000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomization as a basis for inference in noninferiority trials.
    Wiens BL
    Pharm Stat; 2006; 5(4):265-71. PubMed ID: 17128425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A method for sequential analysis of survival data with nonproportional hazards.
    Sooriyarachchi MR; Whitehead J
    Biometrics; 1998 Sep; 54(3):1072-84. PubMed ID: 9750253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.